Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Medtronic
Merck
McKinsey
Baxter

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

PFIZERPEN VK Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Pfizerpen Vk, and what generic alternatives are available?

Pfizerpen Vk is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in PFIZERPEN VK is penicillin v potassium. There are ninety-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

Summary for PFIZERPEN VK
Drug patent expirations by year for PFIZERPEN VK
Synonyms for PFIZERPEN VK
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Potassium
132-98-9
146T0TU1JB
3,3-dimethyl-7-oxo-6-(2-phenoxy-acetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid monopotassium salt
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(( phenoxyacetyl)amino)-, monopotassium salt, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-, monopotassium salt, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-, monopotassium salt, (2S,5R,6R)-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2 -phenoxyacetamido)-, monopotassium salt
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenoxyac etyl)amino]-, monopotassium salt, [2S-(2alpha,5alpha,6beta)]-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-, monopotassium salt, [2S-(2alpha,5alpha,6beta)]-
4-thia-1-azobicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxy-acetamido)-, monopotassium salt
6-(Phenoxyacetamido)penicillanic Acid Potassium
8059-73-2
87-08-1 (Parent)
AC1Q1U2J
AKOS024418766
Antibiocin
API0003778
Apsin VK
Arcacil
Aspin VK
Beepen-VK
beromy cin
Beromycin (penicillin)
beromycin 400
Betapen-VK
BIP0143
C-24392
C16H17N2O5S.K
C16H17N2O5SK
Calciopen K
CAS-132-98-9
CCG-39570
CCRIS 750
CHEBI:7967
CHEMBL1200852
Cilacil
Cliacil
Compocillin-VK
CS-4465
D-alpha-phenoxymethylpencillinate k salt
D-alpha-Phenoxymethylpenicillinate K salt
D00497
Distakaps V-K
Distaquaine V-K
Dov-k
Dowpen V-K
Dqv-K
DSSTox_CID_1102
DSSTox_GSID_21102
DSSTox_RID_75941
DTXSID7021102
EINECS 205-086-5
H887
HCTVWSOKIJULET-LQDWTQKMSA-M
HMS1920F14
HMS2091N14
HMS502G21
HSDB 6315
HY-B0975
Icipen
Isocillin
ispenor al
Ispenoral
Kavepenin
Ledercillin VK
LS-758
Megacillin oral
MFCD00051771
MolPort-003-666-256
Monopotassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
NCGC00164005-01
NCGC00256459-01
NCGC00259725-01
Oracil-VK
Orapen
Ospeneff
Pedipen
Pen VK
Pen-v-k
Pen-V-K powder
Pen-Vee K
pen-vee-k
Pen-Vee-K powder
Penagen
Penapar VK
Pencompren
Penicillin potassium phenoxymethyl
Penicillin V (Potassium)
Penicillin V Pota ssium
Penicillin V potassium
Penicillin V potassium (USP)
Penicillin V potassium [USAN:USP]
Penicillin V Potassium [USAN]
Penicillin V potassium salt
Penicillin V potassium salt, powder, BioReagent, suitable for cell culture
Penicillin V potassium salt, VETRANAL(TM), analytical standard
Penicillin V potassium, United States Pharmacopeia (USP) Reference Standard
PENICILLIN VK
Penicillin-Vk
Penicilline V potassium
Penvikal
phenoxymethylpenicillin potassium
Phenoxymethylpenicillin potassium (JAN)
Phenoxymethylpenicillin potassium salt
Phenoxymethylpenicillin potassium, Antibiotic for Culture Media Use Only
Phenoxymethylpenicillin potassium, British Pharmacopoeia (BP) Reference Standard
Phenoxymethylpenicillin potassium, European Pharmacopoeia (EP) Reference Standard
Phenoxymethylpenicillin Potassium,(S)
Phenoxymethylpenicillinic acid potassium
Phenoxymethylpenicillinic acid potassium salt, potency: >=1460 units per mg
potassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
potassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
potassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(phenyloxy)acetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
potassium 2,2-dimethyl-6beta-(phenoxyacetamido)penam-3alpha-carboxylate
Potassium penicillin V
Potassium penicillin V salt
Potassium phenoxymethyl penicillin
Potassium phenoxymethylpenicillin
potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Primcillin
Qidpen VK
Robicillin VK
Rocillin-VK
Roscopenin
SCHEMBL41271
SK-Penicillin VK
SPECTRUM1500467
Stabillin VK syrup 125
Stabillin VK syrup 62.5
Sumapen VK
Suspen
Tox21_202176
Tox21_302914
UNII-146T0TU1JB
Uticillin VK
V -CIL-K
V-Cil-K
V-Cillin K
v-cillin-k
Veetids
Veetids '125'
Veetids '250'
Veetids '500'
Veetids (TN)
Vepen
Vepicombin
W-109072
ZX-AFC000707

US Patents and Regulatory Information for PFIZERPEN VK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer PFIZERPEN VK penicillin v potassium FOR SOLUTION;ORAL 061815-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer PFIZERPEN VK penicillin v potassium TABLET;ORAL 061836-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer PFIZERPEN VK penicillin v potassium FOR SOLUTION;ORAL 061815-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer PFIZERPEN VK penicillin v potassium TABLET;ORAL 061836-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Harvard Business School
Express Scripts
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.